AAX Biotech in an equity financing transaction with Trio Impact Invest in Sweden
01 February 2026
01 February 2026
Total investments received (USD): 679k
Round value (USD): N/A
Round investors: Trio Impact Invest
Company: AAX Biotech
Industry: BiotechHealth services
Related deals
ToxoTech to raise capital in a round backed by Industrifonden in Sweden
Investments
03 January 2026
Molecular Attraction in a new equity deal backed by UpRoot Capital
Investments
02 January 2026
Belgium
Netherlands
Austria
Germany
Switzerland
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
France
Ireland
Italy
Portugal
Spain